Centre of Neurosurgery, Clinical Hospital "Feofaniya", Zabolotny str, 21, Kyiv, 03143, Ukraine.
Medical Laboratory CSD, Kyiv, 02000, Ukraine.
Rev Recent Clin Trials. 2024;19(3):204-214. doi: 10.2174/0115748871288948240325080936.
Prolactinomas are the most common type of pituitary gland tumors that secrete overly prolactin. They account for approximately 60% of all hormone-secreting hypophysis tumors.
This study aims to analyze gender differences in patients with prolactinomas who were operated on transsphenoidal surgery and conduct a single-center retrospective analysis of patient data.
This study evaluated the medical records of 109 patients (61 females and 48 males) from 2009 to 2019 at Feofaniya Clinical Hospital of the State Administration of Affairs in Kyiv, Ukraine. The primary criterion for including patients was a Serum Prolactin (PRL) level of over 100 ng/ml and the presence of a pituitary adenoma (PA) as observed on MRI. Additionally, the histological examination needed to confirm the presence of Prolactin-Secreting Pituitary Adenomas (PSPAs) without plurihormonal activity through both microscopy and immunohistochemical (IHC) staining.
Significant differences in preoperative PRL levels were not observed. However, males had significantly larger tumor sizes and prevalence of macroadenomas. In male patients, the preoperative PLR levels showed a weak negative correlation with age (r=-0.304, p < 0.036) and a positive correlation with tumor size (r=0.555, p < 0.001) and cavernous sinus invasion (r=0.339, p < 0.018). In females, preoperative PRL was significantly associated only with tumor size and Knosp grade.
Prolactin-Secreting Pituitary Adenomas (PSPAs) are more common in women than men and are characterized by larger and more invasive tumors with high PRL levels at diagnosis. The PRL level and tumor size before surgery can predict early biochemical remission in both males and females with an accuracy of 58.3% and 68.8%, respectively.
泌乳素瘤是最常见的分泌过多泌乳素的垂体瘤类型。它们约占所有分泌激素的垂体肿瘤的 60%。
本研究旨在分析经蝶窦手术治疗的泌乳素瘤患者的性别差异,并对患者数据进行单中心回顾性分析。
本研究评估了 2009 年至 2019 年乌克兰基辅国家事务管理局费奥法尼亚临床医院 109 名患者(61 名女性和 48 名男性)的病历。纳入患者的主要标准是血清泌乳素(PRL)水平超过 100ng/ml,且 MRI 观察到存在垂体腺瘤(PA)。此外,需要通过显微镜和免疫组织化学(IHC)染色来确认存在泌乳素分泌性垂体腺瘤(PSPAs),而无多激素活性。
术前 PRL 水平无显著差异。然而,男性的肿瘤大小和大腺瘤的患病率明显更大。在男性患者中,术前 PLR 水平与年龄呈弱负相关(r=-0.304,p<0.036),与肿瘤大小呈正相关(r=0.555,p<0.001),与海绵窦侵犯呈正相关(r=0.339,p<0.018)。在女性中,术前 PRL 仅与肿瘤大小和 Knosp 分级显著相关。
泌乳素分泌性垂体腺瘤(PSPAs)在女性中比男性更常见,其特点是肿瘤更大、更具侵袭性,诊断时 PRL 水平较高。手术前的 PRL 水平和肿瘤大小可以预测男性和女性患者的早期生化缓解,准确率分别为 58.3%和 68.8%。